PFE · 8-K · 20260804PR000094
Alliance Revenue Growth
PFIZER INC · 2026-08-04 · Importance 69 · Surprise 40 · From source text
Second-quarter alliance revenue increased 19% to $2.697 billion, including $2.174 billion from the United States and $523 million internationally. Six-month alliance revenue rose 15% to $5.036 billion, with U.S. alliance revenue up 14% to $4.046 billion and international alliance revenue up 20% to $990 million. Second-quarter royalty revenue increased 11% to $474 million, while six-month royalty revenue increased 19% to $870 million. The growth reflects the contribution of alliance- and royalty-based products including Eliquis, Xtandi, Adcetris and Orgovyx.
Key facts
- Total Alliance revenues in Second-Quarter 2026 included above: $2,697 million, up 19% (or 18% operational) versus 2025; U.S. $2,174 million, up 18%; International $523 million, up 20% source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +2.8% | Total Alliance revenues in Second-Quarter 2026 included above: $2,697 million, up 19% (or 18% operational) versus 2025; U.S. $2,174… |